Skip Tonight's Dose and Recheck Level
Yes, skip tonight's 600mg dose and recheck your lithium level in 12 hours (before your morning dose). A level of 1.4 mmol/L exceeds the recommended therapeutic range and warrants immediate dose adjustment, even without overt toxicity symptoms.
Why This Level Requires Action
Your lithium level of 1.4 mmol/L is above the standard therapeutic range of 0.6-1.2 mmol/L for maintenance therapy 1. The FDA label explicitly states that "toxic levels for lithium are close to the therapeutic levels" and that "patients abnormally sensitive to lithium may exhibit toxic signs at serum levels of 1 to 1.5 mEq/L" 1. Importantly, toxicity can occur even at therapeutic or near-therapeutic levels, particularly in certain patient populations 2, 3, 4.
Immediate Management Steps
- Skip tonight's 600mg dose - This allows the level to decline naturally
- Recheck lithium level in 12 hours (before your next scheduled morning dose) to assess the decline
- Monitor for any emerging symptoms including:
- Tremor (most common early sign)
- Confusion or altered mental status
- Gait disturbance or unsteadiness
- Slurred speech
- Nausea, vomiting, or diarrhea
- Muscle twitching 4
Critical Context: Toxicity Without Symptoms
The absence of symptoms does NOT guarantee safety at this level. Multiple case reports document that clinically significant lithium toxicity can occur at therapeutic or near-therapeutic serum concentrations 2, 3, 4. In one systematic review, approximately 19% of toxicity cases occurred despite therapeutic lithium levels 4. Neurological manifestations can develop insidiously, with tremor being the most frequent initial symptom (61.9% of cases), followed by altered mental status and gait disturbance 4.
Risk Factors That Lower Your Toxicity Threshold
Your risk of toxicity at this level increases if you have:
- Age ≥50 years (older adults require lower targets of 0.5-0.6 mmol/L) 5, 6
- Reduced renal function (elevated creatinine occurs in two-thirds of toxicity cases) 4
- Concurrent medications: NSAIDs, diuretics, ACE inhibitors, antipsychotics, or antidepressants 7, 4, 8
- Dehydration, fever, or acute illness 7
- Poor dietary intake or reduced sodium 9
The KDIGO guidelines specifically recommend "temporary discontinuation of potentially nephrotoxic and renally excreted drugs" including lithium "in people with serious intercurrent illness that increases the risk of AKI" 7.
Resuming Lithium After Level Normalizes
Once your level drops to the therapeutic range (ideally 0.6-0.8 mmol/L for most maintenance therapy):
- Resume at a reduced total daily dose - likely 900mg/day (300mg AM, 600mg HS) or 600mg/day (300mg twice daily)
- The FDA label notes that "early symptoms of lithium toxicity can usually be treated by reduction or cessation of dosage of the drug and resumption of the treatment at a lower dose after 24 to 48 hours" 1
- Recheck level in 5-7 days after resuming to ensure stability in therapeutic range
- Continue monitoring every 2 months during stable maintenance therapy 1
Long-Term Monitoring Requirements
Guidelines emphasize that lithium requires regular monitoring of 7:
- Serum lithium levels every 3-6 months (or more frequently with dose changes)
- Renal function (creatinine, BUN) every 3-6 months
- Thyroid function (TSH) every 3-6 months
- Electrolytes every 3-6 months
- Urinalysis periodically
Common Pitfall to Avoid
Do not rely solely on serum levels to determine toxicity. The guidelines stress that "total reliance must not be placed on serum levels alone. Accurate patient evaluation requires both clinical and laboratory analysis" 1. Clinical signs of toxicity should prompt immediate action regardless of the numerical level, and conversely, levels above 1.2 mmol/L warrant intervention even without symptoms.